Engaging Children in Brain-Computer Interface (BCI) Development: Utilizing an Interactive iPad Tool to Capture Picture-Based P300-Based BCI Augmentative and Alternative Communication Design Preferences.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος:	Engaging Children in Brain-Computer Interface (BCI) Development: Utilizing an Interactive iPad Tool to Capture Picture-Based P300-Based BCI Augmentative and Alternative Communication Design Preferences.
Συγγραφείς:	Pitt KM; Department of Special Education and Communication Disorders, University of Nebraska-Lincoln., Thiessen A; Department of Communication Sciences and Disorders, University of Houston, TX., Fowler G; Department of Special Education and Communication Disorders, University of Nebraska-Lincoln., Butler E; Department of Biological Systems Engineering, University of Nebraska-Lincoln.
Πηγή:	American journal of speech-language pathology [Am J Speech Lang Pathol] 2026 Sep 08; Vol. 35 (5), pp. 2351-2363. Date of Electronic Publication: 2026 Aug 24.
Τύπος έκδοσης:	Journal Article
Γλώσσα:	English
Στοιχεία περιοδικού:	Publisher: American Speech-Language-Hearing Association Country of Publication: United States NLM ID: 9114726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-9110 (Electronic) Linking ISSN: 10580360 NLM ISO Abbreviation: Am J Speech Lang Pathol Subsets: MEDLINE
Imprint Name(s):	Original Publication: Rockville Md : American Speech-Language-Hearing Association
Ιατρικοί όροι (MeSH):	Event-Related Potentials, P300/physiology , Brain-Computer Interfaces , Communication Devices for People with Disabilities*, Humans ; Child ; Female ; Male ; Photic Stimulation ; Electroencephalography ; Choice Behavior
Περίληψη:	Introduction: P300-based brain-computer interface augmentative and alternative communication (P300-BCI-AAC) systems show promise for supporting communication for children with severe speech and physical impairments. However, little is known about how children prefer these displays to be designed. This study examined children's design choices and the rationales guiding those choices to inform the development of user-centered, pediatric BCI-AAC displays. Method: Thirty-eight typically developing children (8-12 years of age) used a P300-BCI-AAC design application to create their preferred picture-based interface. Participants selected features such as color, animation, and overlays. Semistructured interviews followed to capture reasons for their decisions. Results: Two themes guided design decisions: (a) supporting visual distinction to make items more recognizable and (b) personal factors influencing design choices. Most children selected preferred colors; animation effects, especially zooming animations; and sound cues. Animation was frequently chosen to help with visual accessibility and ease of target location and to support general personalization, whereas changes in background colors were commonly used to support the incorporation of preferred colors, and video GIFs and picture overlays commonly supported the incorporation of personal relevance. Some participants emphasized symbol visibility or reduced intensity. Conclusions: Findings underscore the preliminary importance of motion, color, personalization, and visual clarity in pediatric BCI-AAC interfaces. These insights provide a foundation for developing customizable, engaging P300-BCI-AAC systems and highlight the need for research involving children who use AAC in daily life. Research incorporating individuals with motor difficulties is warranted to refine and extend conclusions. Supplemental Material: https://doi.org/10.23641/asha.33289134.
References:	Augment Altern Commun. 2019 Mar;35(1):13-25. (PMID: 30663899) Disabil Rehabil Assist Technol. 2025 Jan;20(1):171-183. (PMID: 38808372) Am J Speech Lang Pathol. 2022 Jan 18;31(1):515-526. (PMID: 34958737) Augment Altern Commun. 2017 Sep;33(3):160-169. (PMID: 28617614) Front Hum Neurosci. 2021 Jul 14;15:643294. (PMID: 34335203) Ann Phys Rehabil Med. 2015 Feb;58(1):35-38. (PMID: 25595535) Assist Technol. 2018;30(4):183-190. (PMID: 28430027) J Neurosci Methods. 2008 Jan 15;167(1):43-50. (PMID: 17399797) Augment Altern Commun. 2018 Jun;34(2):155-165. (PMID: 29661042) PLoS One. 2014 Dec 03;9(12):e112392. (PMID: 25469774) Augment Altern Commun. 2024 Mar;40(1):57-67. (PMID: 37811949) Am J Speech Lang Pathol. 2018 Feb 6;27(1):1-12. (PMID: 29318256) Int J Speech Lang Pathol. 2015;17(5):460-9. (PMID: 25592055) Clin Neurophysiol. 2013 Feb;124(2):327-38. (PMID: 22959257) J Adv Nurs. 2003 Jun;42(5):434-41. (PMID: 12752864) Clin Neurophysiol. 2010 Apr;121(4):516-23. (PMID: 20093075) Perspect ASHA Spec Interest Groups. 2019 Dec;4(6):1622-1636. (PMID: 32529035) Assist Technol. 2024 Oct 30;:1-8. (PMID: 39475413) J Neural Eng. 2008 Dec;5(4):477-85. (PMID: 19015582) IEEE Trans Rehabil Eng. 2000 Jun;8(2):174-9. (PMID: 10896179) Comput Intell Neurosci. 2017;2017:1323985. (PMID: 28487725) J Speech Lang Hear Res. 2019 Apr 15;62(4):965-978. (PMID: 30986148) Am J Speech Lang Pathol. 2010 Feb;19(1):22-33. (PMID: 20139353) Front Hum Neurosci. 2020 Dec 03;14:593883. (PMID: 33343318) Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:6099-6102. (PMID: 33019362) Augment Altern Commun. 2026 Mar;42(1):32-41. (PMID: 40289349) Augment Altern Commun. 2007;23(4):274-87. (PMID: 17852057) Augment Altern Commun. 2008 Mar;24(1):29-42. (PMID: 18938756) Augment Altern Commun. 2007 Sep;23(3):204-16. (PMID: 17701740) J Neural Eng. 2010 Jun;7(3):036003. (PMID: 20404396) Brain Sci. 2022 Aug 18;12(8):. (PMID: 36009160) Front Neurosci. 2020 Jan 31;14:54. (PMID: 32082118) J Speech Lang Hear Res. 2023 Oct 4;66(10):3974-3987. (PMID: 37696046) Augment Altern Commun. 2006 Dec;22(4):269-83. (PMID: 17127615) Cogn Neurodyn. 2018 Feb;12(1):85-94. (PMID: 29435089) J Autism Dev Disord. 2008 Sep;38(8):1499-508. (PMID: 18293074) Augment Altern Commun. 2026 Sep;42(3):255-261. (PMID: 39710873) Augment Altern Commun. 2006 Jun;22(2):85-99. (PMID: 17114167)
Grant Information:	R21 DC021496 United States DC NIDCD NIH HHS
Entry Date(s):	Date Created: 20260824 Date Completed: 20260908 Latest Revision: 20260917
Update Code:	20260917
PubMed Central ID:	PMC13576686
DOI:	10.1044/2026_AJSLP-26-00032
PMID:	42635627
Βάση Δεδομένων:	MEDLINE

Περιγραφή
ISSN:	1558-9110
DOI:	10.1044/2026_AJSLP-26-00032